Kazia Therapeutics Ltd - Company Profile
Powered by
All the data and insights you need on Kazia Therapeutics Ltd in one report.
- Save hours of research time and resources with
our up-to-date Kazia Therapeutics Ltd Strategy Report
- Understand Kazia Therapeutics Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Kazia Therapeutics Limited (Kazia Therapeutics), is an Australian biotechnology company. Focused research and development activities, increase in net working capital and lead product candidate Paxalisib are its key strengths, even as operating losses carry forward are areas of concern to the company. Government regulations, competitive pressures, and uncertain R&D outcomes could have an adverse effect on Kazia Therapeutics business and operating results. However, growing market for cancer treatments, orphan drug designations for its lead drug candidate and unmet medical need of ovarian cancer could present ample growth opportunities to the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer